Driven by new technologies and innovations, the medical device industry has become one of the biggest markets in healthcare. According to the US’s National Center for Biotechnology Information, medical devices and implant numbers have grown to the extent that there are over 1,700 types of devices and 50,000 approved medical devices in the US alone. Over the past decade, this extraordinary growth has led to the development of state-of-the-art health and medical instruments, ranging from simple tongue depressors and bedpans to complex programmable pacemakers with microchip technology and laser surgical devices.

Establishments described in this report are primarily participating in the ultrasound market. An ultrasound is an imaging test that uses sound waves to create a picture (also known as a sonogram) of organs, tissues, and other structures inside the body. Unlike x-rays, ultrasounds don't use any radiation.

Establishments described in this report are primarily participating in the surgical suture market. Surgical suture is a medical device used to hold body tissues together after an injury or surgery. Application generally involves using a needle with an attached length of thread. A number of different shapes, sizes, and thread materials have been developed over its millennia of history.

Establishments described in this report are primarily participating in the tissue diagnostics market. Tissue diagnosis is the diagnosis rendered by a pathologist and is based upon the microscopic examination of a tissue specimen removed during a biopsy / surgical procedure. 4.5k views Answered >2 years ago

Establishments described in this report are primarily participating in the urinalysis market. Urinalysis is a diagnostic physical, chemical, and microscopic examination of a urine sample (specimen). Specimens can be obtained by normal emptying of the bladder (voiding) or by a hospital procedure called catheterization.

Establishments described in this report are primarily participating in the transplant diagnostics market. Transplant diagnostics are clinical diagnostic tools that help to improve the efficiency of transplantation procedures. HLA typing is of utmost importance in applications such as organ and blood stem cell transplantation.

Establishments described in this report are primarily participating in the viral clearance market. Viral clearance refers to the time it takes for a virus to no longer be detected in tests. At that point, the body's immune system and treatments have successfully removed evidence of the virus. The amount of time it takes for a virus to clear from the system varies for each virus and can vary from person to person.

Establishments described in this report are primarily participating in the veterinary electrosurgery market. Veterinary electrosurgery is the application of a radio frequency with alternating polarity of electric current to coagulate, or cut the biological tissue. Veterinaryelectrosurgical devices are used to make precise cuts and further controlling blood loss by coagulationat the surgical site during procedures.

Establishments described in this report are primarily participating in the surgical tourniquets market. Surgical tourniquets enable the surgeons to work in a bloodless operative field by preventing blood flow to a limb and allow surgical procedures to be performed with improved accuracy, safety, and speed.

Establishments described in this report are primarily participating in the surgical imaging market. allow physicians and surgeons to see internal images of the body, including bones and organs, prior to and during surgical procedures. These images help reduce risk and speed recovery.

Establishments described in this report are primarily participating in the vitamins market. A vitamin is an organic molecule that is an essential micronutrient which an organism needs in small quantities for the proper functioning of its metabolism. Essential nutrients cannot be synthesized in the organism, either at all or not in sufficient quantities, and therefore must be obtained through the diet.

作用机理独特，血液瘤作用效果良好。通过基因编辑人体来源的免疫细 胞，使其具备杀伤指定癌细胞、提高机体整体免疫力的能力，因其产品 为活细胞能自行增殖，往往只需要回输一针即可完成治疗。在血液瘤领 域（B 淋巴细胞瘤，骨髓瘤）治疗效果良好，在ORR 和OS 等指标上显 著优于传统药物。

2022 年5 月10 日，罗氏公布其产品TIGIT 抗体Tiragolumab 在 SKYSCRAPER-01的非小细胞肺癌（NSCLC）III期临床试验中，相比单独 使用Tiragolumab 的患者，Tiragolumab 联合Tecentriq 未能延长患者的无 进展生存期（PFS），该试验的总生存期（OS）数据仍在等待中。2022年 3 月，罗氏公布Tiragolumab 在晚期小细胞肺癌III 期临床试验中未成功， Tiragolumab与PD-L1 抗体Tecentriq 加化疗联用在PFS 和OS 终点未能击 败一线疗法Tecentriq加化疗。

5 月31 日，安进宣布olpasiran 在针对脂蛋白(a)增高的II 期OCEAN(a)-DOSE研究中获得积极的关键结果olpasiran是一种小干扰RNA（siRNA），能够减少体内载脂蛋白(a)的生成，从而降低脂蛋白(a)的水平。OCEAN(a)-DOSE 研究纳入了281 例脂蛋白(a)超过150nmol/L（中位水平260nmol/L）并且具有动脉粥样硬化性心血管疾病(ASCVD)症状的患者，分别皮下注射olpasiran 每12 周1 次10mg、75mg、225mg，每24 周1次225mg 或安慰剂，主要终点是第36 周脂蛋白(a)较基线的变化。次要终点是第48 周脂蛋白(a)较基线的变化。

2021 年9 月以来，医疗信息化行业已经有4 家A 股上市公司涉 及了大股东的股权出让问题，其中3 家涉及了控股股东和实际控 制人的变更，股权变更如此集中在行业发展史上实属罕见，因而 我们对行业的股权变更情况做了详细梳理，意图对受让方和出让 方的动向进行更好的理解。

5 月投资策略：部分估值合理、业绩持续稳健增长的标的有望跑出超 额收益， 我们建议关注石药集团（ 01093.HK） 、中国生物制药 （01177.HK）、百济神州（06160.HK）、诺诚健华-B（09969.HK）、 荣昌生物-B（09995.HK）、诺辉健康-B（06606.HK）、海吉亚医疗 （06078.HK）、固生堂（02273.HK）、翰森制药（03692.HK）等。

创新是全球医药产业发展的关键驱动力，也是中国医药产业突破现状更上一层楼的必然路径。身处时代发展浪潮之中时，投资者应坚定拥抱核心趋势，避免过度纠结于短期数据波动与情绪变化。建议关注：1）具备技术平台优势和较强出海能力的创新药龙头；2）估值回调后已进入高性价比区间的CXO龙头，如凯莱英、博腾股份、药石科技、皓元医药、泰格医药、药明康德、康龙化成、昭衍新药。3）创新产业链上游——同时受益于创新驱动的科研与工业市场，重点关注可以向CDMO延伸的特种试剂及具备拓展国际市场实力的模式动物领域，如药康生物、南模生物等。

胶原蛋白因良好的生物性能在美丽和健康领域拥有广阔前景；天然提取法和基因工程重组法均存在巨大提升空间；重组法进步速度相对更快、更易放量。当前，龙头企业在各自的优势品类上有先发优势，未来有望在制备端大幅度降本增效，在产品端孵化出强消费属性大单品、系列的企业有望成为下一站龙头。